Patrick J. Brennan

14.4k citations

90 papers · 10.8k indexed · 5 hit papers · h-index 39

Impact in

Applied Microbiology and Biotechnology top 0.02%
- Antibiotic Use and Resistance
Immunology top 0.5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- Immunotherapy and Immune Responses

Papers in

Infectious Diseases 34
- Leprosy Research and Treatment 22
- Tuberculosis Research and Epidemiology 17
Immunology 36
- Immune Cell Function and Interaction 24
- T-cell and B-cell Immunology 15
- Immune Response and Inflammation 7

Co-authors: Hiroshi Nikaido Manfred Brigl Michael B. Brenner Robert L. Modlin Marianne Billeter John P. Burke John E. McGowan Neil O. Fishman
Journals: Journal of Biological Chemistry (5 papers)Infection and Immunity (5 papers)The Journal of Immunology (4 papers)Biochemistry (3 papers)Nature Immunology (3 papers)
Partner nations: United States United Kingdom France

In The Last Decade

Patrick J. Brennan

90 papers receiving 10.5k citations

Hit Papers

5 papers align trajectories log scale

Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions 2013 · 632 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Nature reviews. Immunology
2006 Clinical Infectious Diseases
1999 Science
1995 Science
1995 Annual Review of Biochemistry

Peers

Countries citing papers authored by Patrick J. Brennan

Since Specialization

Citations

This map shows the geographic impact of Patrick J. Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick J. Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick J. Brennan more than expected).

Fields of papers citing papers by Patrick J. Brennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick J. Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick J. Brennan. The network helps show where Patrick J. Brennan may publish in the future.

Co-authors

The 25 scholars most cited alongside Patrick J. Brennan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Patrick J. Brennan Line = papers co-authored together Patrick J. Brennan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	COVID-19 vaccine uptake before and after a vaccine mandate at a major academic hospital: Trends by race/ethnicity and level of patient contact Vaccine ·Judith Green-McKenzie, Frances S. Shofer, Gregory Kruse, Florence Momplaisir, Patrick J. Brennan, Barbara J. Kuter	2023	3
2	PPARγ agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFRα+ mesenchymal cells JCI Insight ·Ziyu Chen, Soheila Ali Akbari Ghavimi, Mengfan Wu, John McNamara, Olga Barreiro, David E. Maridas, Radomir Kratchmarov, Ashley Siegel, Sarah Djeddi, María Gutiérrez‐Arcelus, Patrick J. Brennan, Timothy P. Padera, Ulrich H. von Andrian, Babak J. Mehrara, Arin K. Greene, C. Ronald Kahn, Dennis P. Orgill, Indranil Sinha, Vicki Rosen, Shailesh Agarwal	2023	4
3	Factors Associated With COVID-19 Vaccine Receipt by Health Care Personnel at a Major Academic Hospital During the First Months of Vaccine Availability JAMA Network Open ·Judith Green-McKenzie, Frances S. Shofer, Florence Momplaisir, Barbara J. Kuter, Gregory Kruse, Usama Bilal, Maryam Behta, Judith A. O’Donnell, Nida Al-Ramahi, Nishaminy Kasbekar, Patricia Sullivan, Philip Okala, Patrick J. Brennan	2021	23
4	P2Y6 Signaling Controls an Innate Alveolar Macrophage-NK Cell Axis That Dampens Type 2 Lung Immunopathology Journal of Allergy and Clinical Immunology ·Jun Nagai, Barbara Balestrieri, Laura B. Fanning, Timothy Kyin, Haley Cirka, Junrui Lin, Patrick J. Brennan, Joshua A. Boyce	2019	1
5	Discovery of Salmonella trehalose phospholipids reveals functional convergence with mycobacteria The Journal of Experimental Medicine ·Peter Reinink, Jeffrey Buter, Vivek Mishra, Eri Ishikawa, Tan‐Yun Cheng, Peter Willemsen, Steffen Porwollik, Patrick J. Brennan, Eva Heinz, Jacob A. Mayfield, Gordon Dougan, Cécile A. C. M. van, Vincenzo Cerundolo, Giorgio Napolitani, Sho Yamasaki, Adriaan J. Minnaard, Michael McClelland, D. Branch Moody, Ildiko Van Rhijn	2019	20
6	Biomarkers for tuberculosis: the case for lipoarabinomannan ERJ Open Research ·Margarida Correia‐Neves, Gabrielle Fröberg, Liudmyla Korshun, Sofía Viegas, Paula Vaz, N. Ramanlal, Judith Bruchfeld, Beston Hamasur, Patrick J. Brennan, Gunilla Källenius	2019	42
7	Activation strategies for invariant natural killer T cells Immunogenetics ·Ayano C. Kohlgruber, Carlos Donado, Nelson M. LaMarche, Michael B. Brenner, Patrick J. Brennan	2016	43
8	iNKT Cell Cytotoxic Responses Control T-Lymphoma Growth In Vitro and In Vivo Cancer Immunology Research ·Hamid Bassiri, Rupali Das, Peng Guan, David M. Barrett, Patrick J. Brennan, Pinaki P. Banerjee, Susan J. Wiener, Jordan S. Orange, Michael B. Brenner, Stephan A. Grupp, Kim E. Nichols	2013	47
9	Codominance of TLR2-Dependent and TLR2-Independent Modulation of MHC Class II in Mycobacterium tuberculosis Infection In Vivo The Journal of Immunology ·Eleanor Kincaid, Andrea J. Wolf, Ludovic Desvignes, Sebabrata Mahapatra, Dean C. Crick, Patrick J. Brennan, Martin S. Pavelka, J. Ernst	2007	42
10	Mapping the laminin-binding and adhesive domain of the cell surface-associated Hlp/LBP protein from Mycobacterium leprae Microbes and Infection ·Cristiana Soares de Lima, Laurence Zulianello, Maria Angela M. Marques, Hee Jin Kim, Michelle Iespa Portugal, Sérgio Luiz Gomes Antunes, Franco D. Menozzi, Tom Henricus Maria Ottenhoff, Patrick J. Brennan, María Cristina Vidal Pessolani	2005	38
11	Identification of Specific Proteins and Peptides in Mycobacterium leprae Suitable for the Selective Diagnosis of Leprosy The Journal of Immunology ·John S. Spencer, Hazel M. Dockrell, Hee Jin Kim, Maria Angela M. Marques, Diana L. Williams, Marcia V. S. B. Martins, Marcio L. F. Martins, Monica C. B. S. Lima, Euzenir Nunes Sarno, Geraldo M. B. Pereira, Haroldo José de Matos, Leila S. Fonseca, E P Sampaio, T.H.M. Ottenhoff, Annemieke Geluk, Sang-Nae Cho, Neil G. Stoker, Stewart T. Cole, Patrick J. Brennan, María Cristina Vidal Pessolani	2005	64
12	The Human CD1-Restricted T Cell Repertoire Is Limited to Cross-Reactive Antigens: Implications for Host Responses against Immunologically Related Pathogens The Journal of Immunology ·Peter A. Sieling, Jordi B. Torrelles, Steffen Stenger, Woosin Chung, Anne E. Burdick, Thomas H. Rea, Patrick J. Brennan, John T. Belisle, Steven A. Porcelli, Robert L. Modlin	2005	17
13	Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells Journal of Clinical Investigation ·Robert E. Hunger, Peter A. Sieling, María Teresa Ochoa, Makoto Sugaya, Anne E. Burdick, Thomas H. Rea, Patrick J. Brennan, John T. Belisle, Andrew Blauvelt, Steven A. Porcelli, Robert L. Modlin	2004	217
14	Langerhans cells utilize CD1a and langerin to efficiently present nonpeptide antigens to T cells Journal of Clinical Investigation ·Robert E. Hunger, Peter A. Sieling, María Teresa Ochoa, Makoto Sugaya, Anne E. Burdick, Thomas H. Rea, Patrick J. Brennan, John T. Belisle, Andrew Blauvelt, Steven A. Porcelli, Robert L. Modlin	2004	200
15	Production and characterization of peptide mimotopes of phenolic glycolipid-I ofMycobacterium leprae FEMS Immunology & Medical Microbiology ·Ju Ho Youn, Han-Jeong Myung, Abraham Liav, Delphi Chatterjee, Patrick J. Brennan, In‐Hong Choi, Sang-Nae Cho, Jeon‐Soo Shin	2004	11
16	T-cell recognition of peptides from the Mycobacterium leprae 35 kDa protein in Thai leprosy patients, healthy contacts, and non-contacts Immunology Letters ·Boosbun Chua-Intra, Sukanya Wattanapokayakit, Sopa Srisungngam, Tawee Srisungngam, Krisada Mahotarn, Patrick J. Brennan, Juraj Iványi	2003	2
17	Lipoarabinomannan fromMycobacterium tuberculosismodulates the generation of reactive nitrogen intermediates by gamma interferon-activated macrophages FEMS Immunology & Medical Microbiology ·Lawrence S.D. Anthony, Delphi Chatterjee, Patrick J. Brennan, Francis E. Nano	1994	17
18	Structural elucidation and antigenicity of a novel phenolic glycolipid antigen from Mycobacterium haemophilum Biochemistry ·Gurdyal S. Besra, Michael McNeil, David E. Minnikin, Françoise Portaels, Malin Ridell, Patrick J. Brennan	1991	20
19	Novel type-specific lipooligosaccharides from Mycobacterium tuberculosis Biochemistry ·Mamadou Daffé, Michael McNeil, Patrick J. Brennan	1991	86
20	Leprosy and the Leprosy Bacillus: Recent Developments in Characterization of Antigens and Immunology of the Disease Annual Review of Microbiology ·Harvey Gaylord, Patrick J. Brennan	1987	79

About Patrick J. Brennan

Patrick J. Brennan is a scholar working on Infectious Diseases, Immunology, Epidemiology, Pharmacology and Microbiology, having authored 90 papers that have together received 10.8k indexed citations. Recurring topics across this work include Mycobacterium research and diagnosis (33 papers), Immune Cell Function and Interaction (24 papers), Leprosy Research and Treatment (22 papers), Tuberculosis Research and Epidemiology (17 papers), Glycosylation and Glycoproteins Research (16 papers), T-cell and B-cell Immunology (15 papers), Carbohydrate Chemistry and Synthesis (15 papers) and Immune Response and Inflammation (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.9k citations), Immunology (3.9k citations), Infectious Diseases (3.4k citations), Molecular Medicine (728 citations) and Epidemiology (4.0k citations). Patrick J. Brennan has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Hiroshi Nikaido, Manfred Brigl, Michael B. Brenner, Robert L. Modlin, Marianne Billeter, John P. Burke, John E. McGowan, Neil O. Fishman, David L. Paterson and Robert A. Weinstein. Their work appears in journals such as Journal of Biological Chemistry, Infection and Immunity, The Journal of Immunology, Biochemistry and Nature Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact